U.S. District Judge David Herndon assigned to handle Pradaxa MDL

This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.

As my regular readers will recall, back in early May 2012 I posted an entry detailing my opinion that a Pradaxa MDL is all but assured and a statement that Pradaxa MDL consolidation would be good for Pradaxa litigation nationwide. Having filed numerous federal lawsuits on behalf of victims of Pradaxa bleeding danger and lectured at seminars for both the American Association for Justice and Mass Torts Made Perfect on Pradaxa bleeding risks, I strongly believed that a Pradaxa MDL would substantially advance Pradaxa bleeding litigation and help streamline the discovery process.

Well, my crystal ball was correct and I am even more pleased with the choice of the JPML for the Pradaxa MDL venue. The good news is that on August 8, 2012, the Judicial Panel on Multidistrict Litigation (JPML) issued an order consolidating all pending and future Pradaxa lawsuits into one MDL in the Southern District of Illinois under the supervision of U.S. District Judge David R. Herndon. Simply put, it is good news for Pradaxa bleeding victims hoping to hold drug maker Boehringer Ingelheim responsible for their injuries.

The JPML, in sending the Pradaxa MDL to East St. Louis, dubbed Herndon an “experienced MDL judge” who “has deftly presided over” multi-district litigation dealing with claims against the Yasmin-line of birth control pills. The Yaz MDL includes more than 9,000 claims. The purpose of the Pradaxa MDL transfer order is to avoid duplication of discovery in Pradaxa litigation, to prevent inconsistent pretrial rulings, and to conserve the resources of the parties, their counsel, and the judiciary. Importantly, transferred Pradaxa bleeding lawsuits not terminated in the transferee district are remanded to their originating transferor districts by the Panel at or before the conclusion of centralized pretrial proceedings.

The Pradaxa MDL is one of the most important pharmaceutical MDL assignments to come about in some time. As I have reported previously, the extent of bleeding dangers posed by Pradaxa approach a national health epidemic. The FDA has found that patients who use Pradaxa are far more likely to have a “serious bleeding event” compared to those who aren’t on the drug.

If you have been a victim of a Pradaxa-related injury or if you or someone you love was taking Pradaxa and suffered a bleeding event, I urge you to contact me directly for a free, no-obligation evaluation of your Pradaxa case.

About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.

Leave a Reply

Your email address will not be published. Required fields are marked *

    Contact Us Today

    Contact our lawyers directly through the email form below.





    Type of Case

    How did you find out about us?

    ×
    What Our Clients Are Saying